|
|
|
|
|
|
|
|
|
31.07.25 - 16:54
|
Asahi Kasei Q1 Net Income Declines (AFX)
|
|
|
TOKYO (dpa-AFX) - Asahi Kasei Corp. (AHKSF), on Thursday reported a decline in net income for the first quarter of 2025, while revenue was slightly up from the prior year. Net income for the perio......
|
|
|
31.07.25 - 12:01
|
Asahi Kasei liefert Batterie-Separatoren an Toyota-Tochter (Electrive)
|
|
|
Das japanische Technologieunternehmen Asahi Kasei ist eine strategische Partnerschaft mit Toyota Tsusho für die Lieferung von Lithium-Ionen-Batterieseparatoren in Nordamerika eingegangen. Die beiden japanischen Unternehmen wollen damit ihre US-Lieferketten stärken....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.05.25 - 07:00
|
PeptiSystems and Asahi Kasei Bioprocess America enter exclusive global partnership for peptide synthesis (Cision)
|
|
|
PeptiSystems, a biotech company specializing in innovative manufacturing solutions for peptide and oligonucleotide drugs, has formed an exclusive global partnership with Asahi Kasei Bioprocess America (AKBA), a leading provider of advanced bioprocessing equipment solutions. The collaboration combines PeptiSystems' flow-through instrument platform with AKBA's high-performance column technology – giving customers a streamlined and reliable setup from the very first run.
[PeptiSystems-Asahi-Kasei-Bioprocess-America-global-partnership-peptide-synthesis.png]
As part of the partnership,...
|
|
|
|
|
|
|
|
|
|
|
|
|
24.04.25 - 14:54
|
Ken Shinomiya Becomes Leader of Asahi Kasei′s Healthcare Sector (Business Wire)
|
|
|
Leading the way for the sector's continued growth and commitment to improving patient outcomes
CHELMSFORD, Mass. & NOVI, Mich. & DÜSSELDORF, Germany & TOKYO--(BUSINESS WIRE)--Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, as the Leader of its Healthcare Sector succeeding Richard Packer. Under Shinomiya, Asahi Kasei's Healthcare Sector will further advance its portfolio and global presence of pharmaceuticals, life science, and critical care products and services.
Having served as Vice President of Strategy at ZOLL Medical Corporation from fiscal 2016 to fiscal 2017, Shinomiya became Head of the Bioprocess Division of Asahi Kasei Medical in April 2019 and President of Asahi Kasei Medical in April 2023. In April 2025, he was named President of Asahi Kasei Life Science, the successor company to the bioprocess business of Asahi Kasei Medical. With operations focused on products and services that support the manufacture of pharmaceuticals, the life science business has grown ...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
